Login| Sign Up| Help| Contact|

Patent Searching and Data


Matches 1 - 50 out of 31,942

Document Document Title
WO/2018/104856A1
A process of obtaining a purified geometric isomer of an unsaturated macrocyclic compound is disclosed herein. The process is effected by contacting an ion exchange medium comprising silver ions with a mixture comprising at least one geo...  
WO/2018/104305A1
Substituted aromatic sulfonamides of formula (I) which are antagonists or negative allosteric modulators of P2X4, pharmaceutical compositions and combinations comprising said compounds and the use of said compounds for manufacturing a ph...  
WO/2018/104295A1
Disclosed are sulfonamide analogues of galiellactone of formula (I) as STAT3-inhibitors for use in the treatment of a STAT3 signaling related disorder, e.g. solid cancers, hematological cancers, benign tumors, hyperproliferative diseases...  
WO/2018/102427A1
Provided herein are methods of preparation of I by reacting i with acid where R1 and R2 are each independently a leaving group. Intermediates to make i are also claimed.  
WO/2018/099432A1
The present invention relates to a fused ring compound and a preparation method and application thereof. The fused ring compound is represented by general formula (I). The fused ring compound emits fluorescence at a short wavelength, and...  
WO/2018/100184A1
The invention relates to a method for producing 5-hydroxymethylfurfural (HMF) in a continuous process, which leads to the obtainment of an HMF fraction, a carbohydrate/acid fraction, a fructose fraction, and a levulinic-acid and formic-a...  
WO/2018/100016A1
The present invention relates to 1-fluorocyclohexyl-methoxy-aryl compounds of formula (I), in which R1, R2, A1, A2, m and n are defined as indicated in claim 1, to their production, to their use as components in liquid crystal media and ...  
WO/2018/101329A1
The purpose of the present invention is to develop a therapeutic agent for inflammatory diseases such as inflammatory bowel disease and NASH, said therapeutic agent having few adverse effects and high efficacy. The present invention prov...  
WO/2018/100515A1
The invention relates to novel ruthenium complexes of formula (9). The invention also relates to the method for preparation of novel metal complexes of formula (9) and their use in olefin metathesis reactions.  
WO/2018/098831A1
Provided are a biomass-based epoxy resin and method for preparation thereof; under conditions of N,N-dimethylformamide as a catalyst, 2,5-furandicarboxylic acid and thionyl chloride are acylated to obtain 2,5-furan diformyl chloride; the...  
WO/2018/094487A1
The present invention relates to the process of enzymatic epoxidation of terpenes using lipase and hydrogen peroxide, to epoxidized compounds and to the use of the compounds as an antiproliferative agent. Enzymatic epoxidation was carrie...  
WO/2018/097654A2
The present specification provides a coating composition comprising a fluorene derivative, an organic light emitting device formed by using the coating composition, and a method for manufacturing the same.  
WO/2018/095287A1
Disclosed are a benzoheterocyclyl alkylamine compound, or a pharmaceutically acceptable salt thereof, or a stereoisomer thereof, and a preparation method therefor, and a use of the same for preparing antibacterial medicines as an inhibit...  
WO/2018/095940A1
The present invention relates to Bisbenzofuran-fused indeno[1,2-b]fluorene derivatives and related compounds as materials for organic electroluminescent devices (OLEDs).  
WO/2018/095888A1
The present invention relates to bisbenzofuran-fused 2,8-diaminoindeno[1,2-b]fluorene derivatives and related compounds of formula (1) as materials for organic electroluminescent devices (OLEDs).  
WO/2018/096401A1
The present invention provides a compound useful as a novel antitumor agent targeting a CSC that is important in continuous proliferation of malignant tumor, metastasis and recurrence of cancer, and its resistance to an antitumor agent; ...  
WO/2018/097725A1
A process for treating a furan-2,5-dicarboxylic acid composition, which process comprises: introducing a furan-2,5-dicarboxylic acid composition, which furan-2,5-dicarboxylic acid composition contains an impurity compound and which impur...  
WO/2018/097726A1
A process for treating a dicarboxylic acid composition, with the proviso that the dicarboxylic acid is not furan 2,5-dicarboxylic acid, which process comprises: - introducing a dicarboxylic acid composition, which dicarboxylic acid compo...  
WO/2018/097944A1
Compounds of Formula (I) and Formula (II), pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and have use in treating cardiovascular and other conditions...  
WO/2018/093080A1
The present invention provides a novel compound and an organic light-emitting device using same.  
WO/2018/090149A1
The present invention describes slow-release compositions for the effective delivery of active ingredients such as putrescine and Vitamin C into the skin. These compositions may be used in a variety of cosmetic and therapeutic applicatio...  
WO/2018/093015A1
The present invention provides an organic light-emitting device having an improved driving voltage, efficiency, and lifespan.  
WO/2018/093413A1
A method for preparing sugar-based mono and diesters is described. The process entails the esterification of 2,5-furan-dicarboxylic acid (FDCA) with an alcohol in the presence of low loadings of a homogeneous organotin (IV) catalyst.  
WO/2018/094334A1
Prodrugs of hydroxamate-based GCPII inhibitors and methods of their use for treating a disease or condition are disclosed.  
WO/2018/093818A1
Pharmaceutical compositions of the invention comprise functionalized lactone derivatives having a disease-modifying action in the treatment of diseases associated with dysregulation of 5-hydroxytryptamine receptor 7 activity.  
WO/2018/090921A1
Disclosed are a class of URAT1 inhibitor compounds and the use of such compounds. These compounds are compounds represented by the structure of formula (I) or pharmaceutically acceptable salts thereof. Experiments show that the compounds...  
WO/2018/090717A1
Provided are an ATG analogue, a preparation method therefor and a use thereof, the specific structure of the ATG analogue is as shown in the following three general formulae: formula (I), formula (II), and formula (III) wherein X/Y/Z can...  
WO/2018/094122A1
The present invention provides methods and compositions for treating atopic dermatitis by cyclohexenone compounds.  
WO/2018/093135A2
The present invention relates to a method for preparing 2-hydroxy-gamma-butyrolactone through a biosynthesis pathway and, more specifically, to a method for preparing 2-hydroxy-gamma-butyrolactone from 3-hydroxypropionic acid and formic ...  
WO/2018/088670A1
Provided are: a compound including a positive ion and a negative ion, the positive ion being represented by a specific chemical formula; a photosensitive resin composition including the same; and a color filter produced by using the phot...  
WO/2018/089402A1
There are described RORĪ³ Gamma modulators of the formula (I), (I) or stereoisomers, tautomers, pharmaceutically acceptable salts, solvates, or prodrugs thereof, wherein all substituents are defined herein. Also provided are pharmaceutic...  
WO/2018/089600A1
Disclosed are bio-based mono-ethylene glycol (MEG) compositions containing from about 1 ppm to about 5000 ppm of at least one C3-C12 1,2-diol, bio-basedpolyester compositions made therefrom, and methods of making the same are disclosed. ...  
WO/2018/087270A1
The invention relates to a process for the hydrogenation of a composition comprising hydroxymethylfurfural, bishydroxymethylfuran or mixtures thereof to obtain a composition comprising cis-(tetrahydrofuran-2,5-diyl)dimethanol and trans-(...  
WO/2018/085957A1
Disclosed is a process for the production of an aromatic compound comprising at least two amine functions, comprising reacting an aromatic compound having at least one hydroxyl function and at least one aldehyde function with a second re...  
WO/2018/086491A1
Provided is a process for the production of an aromatic compound comprising at least two amine functions, comprising reacting an aromatic compound having at least one hydroxyl function and at least one aldehyde function with a second rea...  
WO/2018/082234A1
A method for preparing 2,5-Furandicarboxylic acid by catalytic oxidation of 2,5-Diformylfuran. The method uses hyperoxide as an oxygen source; the 2,5-Diformylfuran is oxidized to be the 2,5-Furandicarboxylic acid under the effect of a s...  
WO/2018/085179A1
Disclosed is a process for the extraction of furfural. The process includes subjecting a composition comprising furfural, water, at least one acid and an aromatic solvent, with a boiling point higher than that of furfural, to a first sep...  
WO/2018/085176A1
Disclosed is a process for the extraction of furfural which includes: (a) subjecting a composition comprising furfural, water, at least one acid and an aromatic solvent, with a boiling point higher than that of furfural, to a first separ...  
WO/2018/083053A1
The present invention relates to fluoranthenyl-amine compounds according to a formula (I). Said compounds are suitable for use in electronic devices. The invention also relates to a method for producing said compounds, and to electronic ...  
WO/2018/084266A1
Herein disclosed are compounds, compositions, kits, and methods of treating cancers using 7-azaindolyl furanone/thiophene derivatives. These derivatives inhibit serine-threonine kinase Cdc7, a recognized anticancer target affecting DNA r...  
WO/2018/085182A1
Disclosed is a process for the extraction of furfural including: (a) subjecting a composition comprising furfural, water, at least one inorganic acid, at least one organic acid and a solvent mixture comprising an aromatic solvent and an ...  
WO/2018/085174A1
A process for the extraction of furfural from a composition comprising furfural, water, at least one organic acid and an oxygenate solvent with a boiling point higher than that of furfural. The process includes: (a) subjecting the compos...  
WO/2018/084423A2
The present invention provides a novel heterocyclic compound and an organic light emitting element using the same.  
WO/2018/076537A1
Disclosed are a D-3-phosphoglycerate dehydrogenase allosteric inhibitor and the use thereof, wherein one class is the benzoyl hydrazine compound for the allosteric site MDL-1 of the enzyme, and the other class is the furan compound for t...  
WO/2018/072289A1
Disclosed is a method for preparing a maleate by a selective catalytic oxidation of lignin. The method, by using a heteropolyacid functionalized ionic liquid as a catalyst and an alcohol-water solution as a reaction medium, achieves effi...  
WO/2018/070641A2
The present invention relates to a compound represented by chemical formula 1 for an organic optoelectronic element, an organic optoelectronic element employing the same, and a display device. The details for chemical formula 1 above are...  
WO/2018/071327A1
This disclosure relates to the field of molecules having pesticidal utility against pests in Phyla Arthropoda, Mollusca, and Nematoda, processes to produce such molecules, intermediates used in such processes, pesticidal compositions con...  
WO/2018/065611A1
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain 2-amino-N-(arylsulfinyl)- acetamide compounds that, inter alia, inhibit (e.g., selectively inhibi...  
WO/2018/065475A1
A process for the preparation of methylsuccinic acid in any form, including its salts, its mono- and diester derivatives and the anhydride thereof, which comprises reacting citric acid or a derivative thereof in decarboxylation condition...  
WO/2018/066783A1
The present invention relates to a composition for an organic optoelectronic element, the composition comprising: a first host compound represented by chemical formula 1 below; and a second host compound represented by chemical formula 2...  

Matches 1 - 50 out of 31,942